Tag: Exparel

Effective postoperative pain management is crucial for patient recovery after foot and ankle surgery. When considering what drug is in a popliteal block, the selection involves specific local anesthetics and possible additives tailored to the patient and procedure's needs.

As of November 2023, the U.S. Food and Drug Administration (FDA) has approved an expanded label for Exparel, specifically indicating its use for a sciatic nerve block in the popliteal fossa in adults. This makes it a standard, FDA-approved option for regional anesthesia in specific foot and ankle surgeries.

Bupivacaine, a widely used medication since its discovery in 1957, is a long-acting local anesthetic used to numb specific areas of the body. For individuals preparing for a procedure or interested in pharmacology, understanding **what class of anesthetic is bupivacaine** is crucial to grasp its specific properties and safety profile.

First FDA-approved in 2011, EXPAREL is a brand-name, extended-release, non-opioid medication used for postsurgical pain relief. The core of what is an EXPAREL injection lies in its unique technology, which delivers a local anesthetic over several days, targeting pain at the surgical site.